A detailed history of Tokio Marine Asset Management CO LTD transactions in Amgen Inc stock. As of the latest transaction made, Tokio Marine Asset Management CO LTD holds 15,412 shares of AMGN stock, worth $4.54 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
15,412
Previous 14,663 5.11%
Holding current value
$4.54 Million
Previous $4.58 Million 8.38%
% of portfolio
0.22%
Previous 0.22%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$309.38 - $337.38 $231,725 - $252,697
749 Added 5.11%
15,412 $4.97 Million
Q2 2024

Jul 26, 2024

BUY
$262.75 - $319.31 $210,988 - $256,405
803 Added 5.79%
14,663 $4.58 Million
Q1 2024

May 02, 2024

BUY
$268.87 - $324.56 $315,922 - $381,358
1,175 Added 9.26%
13,860 $3.94 Million
Q4 2023

Feb 02, 2024

BUY
$255.7 - $288.46 $141,657 - $159,806
554 Added 4.57%
12,685 $3.65 Million
Q3 2023

Nov 02, 2023

BUY
$218.65 - $271.46 $244,669 - $303,763
1,119 Added 10.16%
12,131 $3.26 Million
Q2 2023

Jul 28, 2023

BUY
$214.27 - $253.37 $86,136 - $101,854
402 Added 3.79%
11,012 $2.44 Million
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $251,981 - $307,123
1,116 Added 11.75%
10,610 $2.56 Million
Q4 2022

Jan 26, 2023

BUY
$229.03 - $291.01 $225,365 - $286,353
984 Added 11.56%
9,494 $0
Q3 2022

Nov 10, 2022

BUY
$224.46 - $253.15 $282,146 - $318,209
1,257 Added 17.33%
8,510 $1.92 Million
Q2 2022

Aug 09, 2022

BUY
$230.71 - $256.74 $259,779 - $289,089
1,126 Added 18.38%
7,253 $1.77 Million
Q1 2022

May 13, 2022

BUY
$219.27 - $242.57 $195,150 - $215,887
890 Added 16.99%
6,127 $1.48 Million
Q4 2021

Jan 26, 2022

BUY
$198.88 - $227.6 $31,423 - $35,960
158 Added 3.11%
5,237 $1.18 Million
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $127,362 - $149,220
600 Added 13.4%
5,079 $1.08 Million
Q2 2021

Aug 12, 2021

BUY
$233.58 - $259.14 $91,329 - $101,323
391 Added 9.56%
4,479 $1.09 Million
Q1 2021

May 17, 2021

BUY
$221.91 - $258.6 $133,146 - $155,160
600 Added 17.2%
4,088 $1.02 Million
Q4 2020

Feb 16, 2021

BUY
$216.38 - $257.67 $33,538 - $39,938
155 Added 4.65%
3,488 $802,000
Q3 2020

Nov 09, 2020

BUY
$234.65 - $260.95 $76,965 - $85,591
328 Added 10.92%
3,333 $847,000
Q2 2020

Aug 07, 2020

BUY
$197.81 - $242.74 $67,848 - $83,259
343 Added 12.89%
3,005 $709,000
Q1 2020

May 12, 2020

BUY
$182.24 - $241.7 $96,040 - $127,375
527 Added 24.68%
2,662 $540,000
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $26,489 - $34,048
140 Added 7.02%
2,135 $515,000
Q3 2019

Oct 29, 2019

BUY
$174.11 - $208.62 $38,652 - $46,313
222 Added 12.52%
1,995 $386,000
Q2 2019

Jul 25, 2019

BUY
$166.7 - $195.41 $36,007 - $42,208
216 Added 13.87%
1,773 $327,000
Q1 2019

Apr 25, 2019

BUY
$180.87 - $203.88 $37,259 - $41,999
206 Added 15.25%
1,557 $296,000
Q4 2018

Feb 04, 2019

BUY
$178.4 - $208.25 $30,149 - $35,194
169 Added 14.3%
1,351 $263,000
Q3 2018

Oct 23, 2018

SELL
$185.29 - $208.89 $103,947 - $117,187
-561 Reduced 32.19%
1,182 $245,000
Q2 2018

Jul 18, 2018

SELL
$166.05 - $186.51 $114,906 - $129,064
-692 Reduced 28.42%
1,743 $322,000
Q1 2018

May 03, 2018

SELL
$169.43 - $198.0 $277,526 - $324,324
-1,638 Reduced 40.22%
2,435 $415,000
Q4 2017

Feb 05, 2018

SELL
$168.79 - $188.59 $272,089 - $304,007
-1,612 Reduced 28.36%
4,073 $708,000
Q3 2017

Oct 30, 2017

SELL
$167.29 - $191.0 $318,520 - $363,664
-1,904 Reduced 25.09%
5,685 $1.06 Million
Q2 2017

Jan 11, 2018

SELL
N/A
-2,750 Reduced 26.6%
7,589 $1.31 Million
Q1 2017

Jan 11, 2018

SELL
N/A
-2,908 Reduced 21.95%
10,339 $1.7 Million
Q4 2016

Jan 11, 2018

SELL
N/A
-5,204 Reduced 28.2%
13,247 $1.94 Million
Q3 2016

Jan 11, 2018

SELL
N/A
-2,467 Reduced 11.79%
18,451 $3.08 Million
Q2 2016

Jan 11, 2018

SELL
N/A
-718 Reduced 3.32%
20,918 $3.18 Million
Q1 2016

Jan 11, 2018

BUY
N/A
21,636
21,636 $3.24 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Tokio Marine Asset Management CO LTD Portfolio

Follow Tokio Marine Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tokio Marine Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tokio Marine Asset Management CO LTD with notifications on news.